443 related articles for article (PubMed ID: 30097823)
1. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
2. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
3. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
Broekx S; Weyns F; De Vleeschouwer S
Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
[TBL] [Abstract][Full Text] [Related]
5. 5-ALA and FDA approval for glioma surgery.
Hadjipanayis CG; Stummer W
J Neurooncol; 2019 Feb; 141(3):479-486. PubMed ID: 30644008
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
Coburger J; Wirtz CR
J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence image-guided neurosurgery.
Kaneko S; Eljamel MS
Future Oncol; 2017 Nov; 13(26):2341-2348. PubMed ID: 29121788
[TBL] [Abstract][Full Text] [Related]
10. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic Acid-Shedding Light on Where to Focus.
Dadario NB; Khatri D; Reichman N; Nwagwu CD; D'Amico RS
World Neurosurg; 2021 Jun; 150():9-16. PubMed ID: 33684574
[TBL] [Abstract][Full Text] [Related]
12. Established and emerging uses of 5-ALA in the brain: an overview.
Díez Valle R; Hadjipanayis CG; Stummer W
J Neurooncol; 2019 Feb; 141(3):487-494. PubMed ID: 30607705
[TBL] [Abstract][Full Text] [Related]
13. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
14. Optimization of high-grade glioma resection using 5-ALA fluorescence-guided surgery: A literature review and practical recommendations from the neuro-oncology club of the French society of neurosurgery.
Picart T; Berhouma M; Dumot C; Pallud J; Metellus P; Armoiry X; Guyotat J
Neurochirurgie; 2019 Aug; 65(4):164-177. PubMed ID: 31125558
[TBL] [Abstract][Full Text] [Related]
15. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature.
Della Puppa A; De Pellegrin S; d'Avella E; Gioffrè G; Rossetto M; Gerardi A; Lombardi G; Manara R; Munari M; Saladini M; Scienza R
Acta Neurochir (Wien); 2013 Jun; 155(6):965-72; discussion 972. PubMed ID: 23468036
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
Chan DTM; Yi-Pin Sonia H; Poon WS
Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-guided surgery for high-grade gliomas.
Lakomkin N; Hadjipanayis CG
J Surg Oncol; 2018 Aug; 118(2):356-361. PubMed ID: 30125355
[TBL] [Abstract][Full Text] [Related]
18. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
[TBL] [Abstract][Full Text] [Related]
19. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
20. Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome.
Barbagallo GMV; Certo F; Di Gregorio S; Maione M; Garozzo M; Peschillo S; Altieri R
Neurosurg Focus; 2021 Jan; 50(1):E20. PubMed ID: 33386001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
